Joseph A. Sowell III - 29 Dec 2021 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
SVP; Chief Development Officer
Signature
/s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
29 Dec 2021
Net transactions value
-$3,723,041
Form type
4
Filing time
03 Jan 2022, 17:38:53 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Options Exercise $1,589,445 +42,750 +346% $37.18* 55,107 29 Dec 2021 Direct F1
transaction HCA Common Stock Tax liability $5,312,486 -20,552 -37% $258.49 34,555 29 Dec 2021 Direct F1
holding HCA Common Stock 21,320 29 Dec 2021 By Trust (Reporting Person and Spouse, Trustees)
holding HCA Common Stock 8,000 29 Dec 2021 By Trust (Reporting Person, Trustee)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -42,750 -100% $0.000000* 0 29 Dec 2021 Common Stock 42,750 $37.18 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2 The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.